|
Match
|
Document |
Document Title |
|
|
7618647 |
Using bucky paper as a therapeutic aid in medical applications
Methods, systems, and uses of bucky paper are provided in the present invention. These embodiments include covering medical implants with single or multiple layers of bucky paper, treating bucky...
|
|
|
7588776 |
Pharmaceutical use of water-soluble fraction of Graptopetalum
A pharmaceutical composition containing a water-soluble fraction of Graptopetalum and its use in treating a liver disease or condition, such as inflammation, steatosis, and fibrosis.
|
|
|
7585516 |
Coatings for drug delivery devices
A polymer coating for medical devices based on a polyolefin derivative. A variety of polymers are described to make coatings for medical devices, particularly, for drug delivery stents. The...
|
|
|
7544368 |
Structure for modulating intraocular pressure
Embodiments of the present invention are directed to three-dimensional porous structures for modulating intraocular pressure. The structures can include a mixture of copolymers, for example,...
|
|
|
7537781 |
Polymer-filler composites for controlled delivery of therapeutic agents from medical articles
A medical article comprising: (a) a therapeutic agent; and (b) a release region comprising (i) a polymer and (ii) a filler comprising inorganic platelet particles. Upon placement of such a medical...
|
|
|
7498042 |
Stent for blood vessel and material for stent for blood vessel
A luminal stent, implanted and implanted and left in the blood vessel, is disclosed. By permitting a stent ( 1 ), formed of a biodegradable polymer material ( 2 ), to be swollen, and by...
|
|
|
7473431 |
Injectable methadone, methadone and naltrexone, or buprenorphine and naltrexone microparticle compositions and their use in reducing consumption of abused substances
An injectable slow-release methadone, partial opioid agonist or opioid antagonist formulation is provided comprising methadone, a partial opioid agonist or opioid antagonist in a poly(D,L-lactide)...
|
|
|
7456213 |
PEG-poly(ortho ester) graft copolymers and pharmaceutical compositions
This invention relates to graft copolymer delivery vehicles comprising a polyethyleneglycol-poly(ortho ester), and to controlled release pharmaceutical compositions comprising the delivery vehicle...
|
|
|
7329789 |
Method for extraction and concentration of carotenoids using supercritical fluids
Carotenoids are extracted and/or enriched from a mixture containing such compounds. The extraction/enrichment process involves the use of liquefied or supercritical solvents to extract lipids and...
|
|
|
7323425 |
Crosslinking of hyaluronan solutions and nanofiberous membranes made therefrom
A method for producing a non-chemically crosslinked hyaluronan is provided which involves contacting a sample of hyaluronan with an acidic solvent/water mixture for a period of time and at a...
|
|
|
7318932 |
Coatings for drug delivery devices comprising hydrolitically stable adducts of poly(ethylene-co-vinyl alcohol) and methods for fabricating the same
A polymer coating for medical devices based on a derivatized poly(ethylene-co-vinyl alcohol) is disclosed. A variety of polymers are described to make coatings for medical devices, particularly,...
|
|
|
7282213 |
Method for applying a drug coating to a medical device
A method for coating a medical device with a drug is provided. Energy, preferably thermal energy, is applied to a crystalline deposit of a drug on the surface of a medical device to increase the...
|
|
|
7186418 |
Composition and use of RAR antagonists for promoting chondrogenesis
The invention provides compositions comprising an RAR antagonist for promoting chondrogenesis and methods employing such compositions for treating cartilage and associated bone abnormalities...
|
|
|
7172765 |
Biodegradable and/or bioabsorbable fibrous articles and methods for using the articles for medical applications
Biodegradable and/or bioabsorable fibrous articles and methods for using the articles in medical applications are disclosed. The biodegradable and/or bioabsorable fibrous articles, which are formed...
|
|
|
7163688 |
Osmotic implant with membrane and membrane retention means
An osmotic delivery system for controlled delivery of a beneficial agent includes an implantable capsule containing a beneficial agent and an osmotic engine that swells on contact with water,...
|
|
|
7160551 |
Injectable system for controlled drug delivery
An injectable composition for delivery of a bioactive agent contains a biocompatible solvent, a hydrophobic polymer, and an amphiphilic block copolymer. The hydrophobic polymer may be a...
|
|
|
7144419 |
Drug-polymer coated stent with blended phenoxy and styrenic block copolymers
The present invention provides a system for treating a vascular condition, including a catheter, a stent coupled to the catheter, a drug-polymer coating on the stent including a polymeric blend of...
|
|
|
7140882 |
Method of producing low molecular weight chitin/chitosan and method of producing an osteoconduction substance
By irradiating 60 Co γ ray to chitin/chitosan, chitin/chitosan having high molecular weight is separated or decomposed into low molecular weight chitin/chitosan. A method of producing an...
|
|
|
7112417 |
Foam composite for the repair or regeneration of tissue
The present patent describes a biocompatible composite made of a first fibrous layer attached to a three-dimensional inter-connected open cell porous foams that have a gradient in composition...
|
|
|
7108862 |
Bone growth compositions and methods
The present invention provides an improved technique for spinal fusion involving the administration of an HMG-CoA reductase inhibitor to a fusion. The HMG-CoA reductase inhibitor is preferably...
|
|
|
7101567 |
Controlled release preparations having multi-layer structure
Preparations whereby two or more drugs can be released separately at appropriate speeds depending on the disease or the release behaviors of one or more drugs can be precisely controlled, which...
|
|
|
7097855 |
Transdermal thermal polymerization
An invention for polymerizing or crosslinking a prepolymer using a water soluble, thermal polymerization initiator is disclosed. The prepolymer mixed with the initiator is injected or placed into...
|
|
|
7090867 |
Controlled release delivery device for pharmaceutical agents incorporating microbial polysaccharide gum
The present invention provides a controlled release device for sustained or pulsatile delivery of pharmaceutically active substances for a predetermined period of time. This invention further...
|
|
|
7045142 |
Sustained release of superoxide dismutase mimics from implantable of insertable medical devices
An implantable or insertable medical device is provided which comprises (a) a superoxide dismutase mimic and (b) a polymeric release region. Upon administration to a patient, the polymeric release...
|
|
|
7041309 |
Spinal fusion using an HMG-CoA reductase inhibitor
An improved technique for spinal fusion including administration of an HMG-CoA reductase inhibitor to the fusion site. The HMG-CoA reductase inhibitor is preferably delivered to the site by a...
|
|
|
7041308 |
Drug-polymer coated stents with segmented homochain copolyesters
The present invention provides a system for treating a vascular condition, including a catheter, a stent coupled to the catheter, a polymeric coating on the stent including a segmented homochain...
|
|
|
7025997 |
Coolant plant extract compositions containing monomenthyl succinate
The present invention relates to plant extracts containing a monomenthyl succinate for use as a coolant in food and non-food products. Methods for isolating the plant extracts are also provided.
|
|
|
7025982 |
Medical assembly suitable for long-term implantation and method for fabricating the same
A process for fabricating a medical assembly having a medical device at least a portion of which is formed of inorganic material is provided. The medical assembly is suitable for substantially...
|
|
|
7022343 |
Controlled release of anti-arrhythmic agents
Methods for the simple, reliable application and local controlled release of selected anti-arrhythmia drugs from a hydrogel applied to or polymerized on the tissues of the heart or its vessels,...
|
|
|
7022334 |
Therapeutic composition and a method of coating implantable medical devices
A therapeutic composition is provided including a polysaccharide or a cationic peptide dissolved in an organic substance. The polysaccharide can be heparin or a derivative of heparin. The cationic...
|
|
|
6976981 |
Osmotic delivery system with membrane plug retention mechanism
An osmotic delivery system has a membrane plug retention mechanism which can also be used to control the delivery rate of a beneficial agent from the osmotic delivery system. The osmotic delivery...
|
|
|
6974679 |
Support with collagen base for tissue engineering and manufacture of biomaterials
The invention relates to a method of in vitro testing of the efficacy of a potentially active substance comprising monitoring the effect of said potentially active substance on an artificial skin,...
|
|
|
6960351 |
Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
An immunoisolatory vehicle for the implantation into an individual of cells which produce a needed product or provide a needed metabolic function. The vehicle is comprised of a core region...
|
|
|
6939557 |
Slow release protein polymers
The invention features articles for delivery of a biologically active substance, methods for making such articles, and methods for treating an animal using the articles.
|
|
|
6936278 |
Microparticles
A process for producing microparticles, in which an aqueous solution of purified amylopectin-based starch of reduced molecular weight is prepared, the solution is combined with biologically active...
|
|
|
6923990 |
Stabilized silver-ion amine complex compositions and methods
The present invention relates to new silver-ion super-complex compositions. More particularly, the present invention describes silver-ion super-complex compositions comprising a silver-thiosulfate...
|
|
|
6913767 |
Compositions for microencapsulation of antigens for use as vaccines
Methods and compositions are provided for the encapsulation of antigens in PLGA microspheres for use as vaccines. Such microspheres can also contain adjuvants. Mixtures of microspheres are provided...
|
|
|
6896894 |
Proteins stabilized with polysaccharide gums
Described are heat stable aqueous solutions or gels comprising a biologically effective amount of a protein and an effective stabilizing amount of a polysaccharide gum as well as heat stable...
|
|
|
6869443 |
Biodegradable drug delivery vascular stent
A stent includes a main body of a generally tubular shape for insertion into a lumen of a vessel of a living being. The tubular main body includes a substantially biodegradable matrix having...
|
|
|
6863899 |
Composite shaped bodies and methods for their production and use
Shaped, composite bodies are provided. One portion of the shaped bodies comprises an RPR-derived porous inorganic material, preferably a calcium phosphate. Another portion of the composite bodies...
|
|
|
6861068 |
Pharmaceutical compositions using semi-solid delivery vehicle
A semi-solid delivery vehicle contains a polyorthoester and an excipient, and a semi-solid pharmaceutical composition contains an active agent and the delivery vehicle. The pharmaceutical...
|
|
|
6858221 |
Intravascular delivery of mycophenolic acid
The present invention provides improved devices and methods for minimizing and/or inhibiting restenosis and hyperplasia after intravascular intervention. In particular, the present invention...
|
|
|
6818224 |
Use of gellable pharmaceutical compositions in periodontology
A method is described for preparing a fluid pharmaceutical composition which allows the controlled release of at least one active substance. The method involves mixing a therapeutically effective...
|
|
|
6793938 |
Biodegradable compositions for the controlled release of encapsulated substances
Pharmaceutical compositions that enable the release of a physiologically active substance over a prolonged period of time following administration to a patient are described. The pharmaceutical...
|
|
|
6790454 |
Processes for the preparation of novel collagen-based supports for tissue engineering, and biomaterials obtained
A composite product is disclosed as a collagen support comprising at least one porous collagen layer covered on at least one side with an essentially compact collagen membrane consisting either of...
|
|
|
6773713 |
Injection molding of living tissues
The invention features methods of making living tissue constructs having a predetermined shape by providing a negative mold having a defined shape; suspending isolated tissue precursor cells in a...
|
|
|
6770729 |
Polymer compositions containing bioactive agents and methods for their use
Embodiments of the invention provide polymer coated implantable medical devices having a bioactive material posited in or on at least a portion of the coating layer, wherein the coating layer...
|
|
|
6767551 |
Coating for use with medical devices and method of making same
The inventive coating may be employed to deliver a pharmaceutical agent to a selected body area that is involved within the insertion or application of a medical device. Such medical devices may...
|
|
|
6767550 |
Hydroxyapatite based drug delivery implant for cancer treatment
A hydroxyapatite based bioresorbable material is incorporated with anti-cancer agents to form an implant used for treatment against cancer. Sustained release of the anti-cancer agents may be...
|
|
|
6764517 |
Tissue repair matrix
A porous three-dimensional tissue repair matrix is provided which is biodegradable. The matrix is preferably formed from mineralized collagen where the mineral comprises particulate calcium...
|